Is your influenza clinical trial prepared for the upcoming flu season? Part 2

November 1, 2024 | COVID, Patient Retention, clinical trials, influenza, patient recruitment 

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell, 2020). A 2023 study calculated that these financial losses can reach approximately $500,000 in lost drug sales and $40,000 in direct clinical trial costs per day of delay (appliedclinicaltrialsonline.com), so the sites chosen to participate in the trial and the support provided to them during patient recruitment can be one of the major deciding factors between an on-time trial and a delayed, over-budget trial.